Physician profile
Crystal Perkins
NPI 1942590773
$4,283.55
in general payments reported to CMS, 2019-2025
15 companies · $198 in 2025
The $198 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,887 · 2020: $16.95 · 2021: $444 · 2022: $1,435 · 2023: $129 · 2024: $172 · 2025: $198.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $499.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $1,830.00 | 2019-2025 | Intellio Link Werewolf, Bioinductive Implant With Arthroscopic Delivery System - Medium, Pico 14 |
| United Orthopedics LLC | $1,200.00 | 2022 | |
| Stryker Corporation | $268.61 | 2021 | |
| Nuvasive Specialized Orthopedics, INC. | $261.81 | 2019-2022 | |
| Vericel Corporation | $131.98 | 2019-2022 | |
| Orthofix Medical, INC. | $120.06 | 2019 | |
| Bioventus LLC | $96.35 | 2023 | |
| Exsomed Corporation | $95.24 | 2022 | |
| Biomarin Pharmaceutical INC. | $91.80 | 2019 | |
| Dynasplint Systems INC. | $54.40 | 2020-2025 | Dynasplint |
| Depuy Synthes Sales INC. | $49.72 | 2019-2023 | Truespan Orthocord, Na |
| Medline Industries LP | $28.96 | 2025 | |
| Genzyme Corporation | $24.71 | 2025 | |
| Convatec INC. | $15.77 | 2025 | |
| Medtronic, INC. | $14.14 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Crystal Perkins listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.